engleski

Oxaliplatin Induced Pulmonary Fibrosis: a Case Report

Oxaliplatin is part of the standard chemotherapy regimens for treating colorectal carcinoma. Pulmonary fibrosis is a serious but rare side effect of oxaliplatin treatment, which resulted in patient death in more than half of the reported cases. The precise pathophysiological mechanism of this phenomenon has not been clarified yet. Analysis of the reported cases strongly suggests that early diagnosis and immediate corticosteroid treatment are crucial for better prognosis. Here we re- port a case of pulmonary fibrosis related to the FOLFOX regimen in a patient with early colorectal carcinoma.

Oxaliplatin ; Colon cancer ; Side effects ; Pulmonary fibrosis ; Interstitial lung disease

nije evidentirano